Paulomycin-related antibiotics: paldimycins and antibiotics 273a2. Isolation and characterization.
The isolation of paulomycins A and B from fermentations of Streptomyces paulus has been reported earlier [J. Antibiotics 35: 285-294, 1982]. Further work on the antibiotics produced by S. paulus revealed the production of two paulomycin-related compounds, antibiotics 273a1 and 273a2 which were isolated by procedures involving extractions and chromatography over buffered silica gel. Antibiotic 273a1 which has been named paldimycin, was found to be a mixture of two materials, paldimycins A and B (antibiotics 273a1 alpha, and 273a1 beta). Similarly, antibiotic 273a2 was found to consist of antibiotic 273a2 alpha and antibiotic 273a2 beta. Paldimycin and antibiotic 273a2, which are produced by addition of two or one molecules of N-acetyl-L-cysteine, respectively, to paulomycins A and B, are active vs. Gram-positive bacteria.
D000900:Anti-Bacterial Agents / Q000302:isolation & purification*; D005285:Fermentation; D013058:Mass Spectrometry; D008837:Micrococcus / Q000187:drug effects; D013053:Spectrophotometry; D013302:Streptomyces / Q000254:growth & development; D013329:Structure-Activity Relationship
D000900:Anti-Bacterial Agents